1,016
Views
42
CrossRef citations to date
0
Altmetric
Reviews

Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions

, MD, , MD, , MD, , MD & , MD
Pages 1247-1266 | Published online: 25 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhendong Liu, Fei Shen, Hongbo Wang, Ang Li, Jialin Wang, Lin Du, Binfeng Liu, Bo Zhang, Xiaoyu Lian, Bo Pang, Liyun Liu & Yanzheng Gao. (2020) Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients. Cell Cycle 19:13, pages 1632-1640.
Read now
David A Reardon, Kai W Wucherpfennig, Gordon Freeman, Catherine J Wu, E Antonio Chiocca, Patrick Y Wen, William T Curry$suffix/text()$suffix/text(), Duane A Mitchell, Peter E Fecci, John H Sampson & Glenn Dranoff. (2013) An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. Expert Review of Vaccines 12:6, pages 597-615.
Read now

Articles from other publishers (40)

Rakesh Trivedi & Krishna P. Bhat. (2023) Liquid biopsy: creating opportunities in brain space. British Journal of Cancer 129:11, pages 1727-1746.
Crossref
Xingbo Cheng, Zhishuai Ren, Zhendong Liu, Xiang Sun, Rongjun Qian, Chen Cao, Binfeng Liu, Jialin Wang, Hongbo Wang, Yuqi Guo & Yanzheng Gao. (2022) Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma. Cancer Cell International 22:1.
Crossref
Alireza Poustforoosh, Mohammad Hadi Nematollahi, Hassan Hashemipour & Abbas Pardakhty. (2022) Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles. Journal of Controlled Release 343, pages 777-797.
Crossref
Susann Haehnel, Michael Rade, Nicole Kaiser, Kristin Reiche, Andreas Horn, Dennis Loeffler, Conny Blumert, Felicitas Rapp, Friedemann Horn, Juergen Meixensberger, Christof Renner, Wolf Mueller, Frank Gaunitz, Ingo Bechmann & Karsten Winter. (2021) RNA sequencing of glioblastoma tissue slice cultures reveals the effects of treatment at the transcriptional level. FEBS Open Bio 12:2, pages 480-493.
Crossref
Halil I. Ciftci, Mohamed O. Radwan, Belgin Sever, Ahmed K. Hamdy, Safiye Emirdağ, N. Gokce Ulusoy, Ece Sozer, Mustafa Can, Nurettin Yayli, Norie Araki, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita & Mehlika Dilek Altintop. (2021) EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy. International Journal of Molecular Sciences 22:20, pages 10945.
Crossref
Aleksandr V. Sokolov, Samira A. Dostdar, Misty M. Attwood, Aleksandra A. Krasilnikova, Anastasia A. Ilina, Amina Sh. Nabieva, Anna A. Lisitsyna, Vladimir N. Chubarev, Vadim V. Tarasov & Helgi B. Schiöth. (2022) Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies. Pharmacological Reviews 73:4, pages 1172-1203.
Crossref
Wojciech Jelski & Barbara Mroczko. (2021) Molecular and Circulating Biomarkers of Brain Tumors. International Journal of Molecular Sciences 22:13, pages 7039.
Crossref
Zhenxing Huang, Gen Li, Zhenye Li, Shengjun Sun, Yazhuo Zhang, Zonggang Hou & Jian Xie. (2021) Contralesional Structural Plasticity in Different Molecular Pathologic Subtypes of Insular Glioma. Frontiers in Neurology 12.
Crossref
Zhenxing Huang, Changyu Lu, Gen Li, Zhenye Li, Shengjun Sun, Yazhuo Zhang, Zonggang Hou & Jian Xie. (2021) Prediction of Lower Grade Insular Glioma Molecular Pathology Using Diffusion Tensor Imaging Metric-Based Histogram Parameters. Frontiers in Oncology 11.
Crossref
Kirsten Ludwig, Sree Deepthi Muthukrishnan, Alvaro G. Alvarado & Harley I. Kornblum. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 1 15 .
Viviane de Cassia Jesus da Silva, Renee de Nazare O. Silva, Lucas Giglio Colli, Maria Helena Catelli de Carvalho & Stephen Fernandes Rodrigues. (2020) Gold nanoparticles carrying or not anti-VEGF antibody do not change glioblastoma multiforme tumor progression in mice. Heliyon 6:11, pages e05591.
Crossref
Cynthia Chauvin, Noémie Joalland, Jeanne Perroteau, Ulrich Jarry, Laura Lafrance, Catherine Willem, Christelle Retière, Lisa Oliver, Catherine Gratas, Laetitia Gautreau-Rolland, Xavier Saulquin, François M. Vallette, Henri Vié, Emmanuel Scotet & Claire Pecqueur. (2019) NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells. Clinical Cancer Research 25:23, pages 7218-7228.
Crossref
K. Mihajluk, C. Simms, M. Reay, P.A. Madureira, A. Howarth, P. Murray, S. Nasser, C.A. Duckworth, D.M. Pritchard, G.J. Pilkington & R. Hill. (2019) IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas. Cancer Letters 458, pages 29-38.
Crossref
Sukru Gulluoglu, Emre Can Tuysuz, Mesut Sahin, Aysegul Kuskucu, Cumhur Kaan Yaltirik, Ugur Ture, Baris Kucukkaraduman, Muhammad Waqas Akbar, Ali Osmay Gure, Omer Faruk Bayrak & Altay Burak Dalan. (2018) Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes. Brain Research 1700, pages 199-210.
Crossref
Qungen Xiao, Minghai Dong, Fangling Cheng, Feng Mao, Weifeng Zong, Kang Wu, Heping Wang, Ruifan Xie, Baofeng Wang, Ting Lei & Dongsheng Guo. (2018) LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling. International Journal of Oncology.
Crossref
Ha Nguyen, Saman Shabani, Ahmed Awad, Mayank Kaushal & Ninh Doan. (2018) Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance. International Journal of Molecular Sciences 19:6, pages 1765.
Crossref
Yawen Ma, Yixue Xue, Xiaobai Liu, Chengbin Qu, Heng Cai, Ping Wang, Zhiqing Li, Zhen Li & Yunhui Liu. (2017) SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153. Oncology Reports 38:5, pages 3265-3277.
Crossref
Kirsten Ludwig & Harley I. Kornblum. (2017) Molecular markers in glioma. Journal of Neuro-Oncology 134:3, pages 505-512.
Crossref
Yawen Ma, Ping Wang, Yixue Xue, Chengbin Qu, Jian Zheng, Xiaobai Liu, Jun Ma & Yunhui Liu. (2017) PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186. Tumor Biology 39:3, pages 101042831769432.
Crossref
BIN DAI, PENG ZHANG, YISONG ZHANG, CHANGCUN PAN, GUOLU MENG, XINRU XIAO, ZHEN WU, WANG JIA, JUNTING ZHANG & LIWEI ZHANG. (2016) RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis. Oncology Reports 36:1, pages 173-180.
Crossref
Haiming LuoReinier HernandezHao HongStephen A. GravesYunan YangChristopher G. EnglandCharles P. TheuerRobert J. NicklesWeibo Cai. (2015) Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry. Proceedings of the National Academy of Sciences 112:41, pages 12806-12811.
Crossref
Ji-wei Ma, Yong Zhang, Ru Li, Jie-cheng Ye, Hai-ying Li, Yi-kai Zhang, Zheng-lai Ma, Jin-ying Li, Xue-yun Zhong & Xuesong Yang. (2015) Tetrandrine suppresses human glioma growth by inhibiting cell survival, proliferation and tumour angiogenesis through attenuating STAT3 phosphorylation. European Journal of Pharmacology 764, pages 228-239.
Crossref
Luigi Battaglia, Marina Gallarate, Elena Peira, Daniela Chirio, Ilaria Solazzi, Susanna Marzia Adele Giordano, Casimiro Luca Gigliotti, Chiara Riganti & Chiara Dianzani. (2015) Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies . Nanotechnology 26:25, pages 255102.
Crossref
Nicole Renee Parker, Peter Khong, Jonathon Fergus Parkinson, Viive Maarika Howell & Helen Ruth Wheeler. (2015) Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications. Frontiers in Oncology 5.
Crossref
XIAOMIN WANG & ZHANYUN GUO. (2015) Chlorotoxin-conjugated onconase as a potential anti-glioma drug. Oncology Letters 9:3, pages 1337-1342.
Crossref
Eric C. Woolf & Adrienne C. Scheck. (2015) The ketogenic diet for the treatment of malignant glioma. Journal of Lipid Research 56:1, pages 5-10.
Crossref
Eric C. Woolf & Adrienne C. Scheck. 2015. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease 125 135 .
SJ Smith, CV Rahman, PA Clarke, AA Ritchie, TW Gould, JH Ward, KM Shakesheff, RG Grundy & R Rahman. (2014) Surgical delivery of drug releasing poly(lactic- co -glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma . The Annals of The Royal College of Surgeons of England 96:7, pages 495-501.
Crossref
Ryan Grant, Luis Kolb & Jennifer Moliterno. (2014) Molecular and genetic pathways in gliomas: the future of personalized therapeutics. CNS Oncology 3:2, pages 123-136.
Crossref
Xiaozhi Liu. (2014) Mesenchymal stem cells show little tropism for the resting and differentiated cancer stem cell-like glioma cells. International Journal of Oncology.
Crossref
Betty M. Tyler, Gustavo Pradilla, Uri Hadelsberg, Hansen Bow, Ian Suk & Henry Brem. 2014. Focal Controlled Drug Delivery. Focal Controlled Drug Delivery 169 194 .
Rohit Duggal, Ulrike Geissinger, Qian Zhang, Jason Aguilar, Nanhai G Chen, Elena Binda, Angelo L Vescovi & Aladar A Szalay. (2013) Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival. Journal of Translational Medicine 11:1.
Crossref
Joachim Høg Mortensen, Maria Jeppesen, Linda Pilgaard, Ralf Agger, Meg Duroux, Vladimir Zachar & Torben Moos. (2013) Targeted Antiepidermal Growth Factor Receptor (Cetuximab) Immunoliposomes Enhance Cellular Uptake In Vitro and Exhibit Increased Accumulation in an Intracranial Model of Glioblastoma Multiforme . Journal of Drug Delivery 2013, pages 1-13.
Crossref
Robert A. Floyd, Hugo C. Castro Faria Neto, Guy A. Zimmerman, Kenneth Hensley & Rheal A. Towner. (2013) Nitrone-based therapeutics for neurodegenerative diseases: Their use alone or in combination with lanthionines. Free Radical Biology and Medicine 62, pages 145-156.
Crossref
Kui Yang, Yunsheng Liu, Zhixiong Liu, Jinfang Liu, Xin Liu, Xin Chen, Chuntao Li & Yu Zeng. (2013) p38γ overexpression in gliomas and its role in proliferation and apoptosis. Scientific Reports 3:1.
Crossref
Patricia L. Zadnik, Ziya L. Gokaslan, Peter C. Burger & Chetan Bettegowda. (2013) Spinal cord tumours: advances in genetics and their implications for treatment. Nature Reviews Neurology 9:5, pages 257-266.
Crossref
Qinhua Guo, Pin Guo, Qing Mao, Jin Lan, Yingying Lin, Jiyao Jiang & Yongming Qiu. (2013) ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways. Medical Oncology 30:1.
Crossref
YT Yeung, KL McDonald, T Grewal & L Munoz. (2013) Interleukins in glioblastoma pathophysiology: implications for therapy. British Journal of Pharmacology 168:3, pages 591-606.
Crossref
Stella Sun, Derek Lee & Gilberto K. K. Leung. 2013. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine 243 270 .
H. Modjtahedi, S. Ali & S. Essapen. (2012) Therapeutic application of monoclonal antibodies in cancer: advances and challenges. British Medical Bulletin 104:1, pages 41-59.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.